FREDUN PHARMACEUTICALS
Back to All Ratios
|
FREDUN PHARMACEUTICALS Last 5 Year Net Sales Growth History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| Net Sales Growth(%) | 40.03 | - |
What is the latest Net Sales Growth ratio of FREDUN PHARMACEUTICALS ?
| Year | Net Sales Growth |
|---|---|
| Mar2026 | 40.03 |
| Mar2025 | - |
How is Net Sales Growth of FREDUN PHARMACEUTICALS Trending?
| Years | Net Sales Growth | % Change | |
|---|---|---|---|
| Mar2026 | 40.03 | 0 | |
| Mar2025 | 0 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Net Sales Growth ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,440.8 Cr | 13.2% | 8% | 221.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 13.2% |
8% |
221.3% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses